Fig. 5From: Insights on the interaction of SARS-CoV-2 variant B.1.617.2 with antibody CR3022 and analysis of antibody resistancea The observed RMSD with respect to time. b Time versus RMSF of protein antibody for Wild_CR3022 and Model2_CR3022. c Time versus RMSF of protein antibody for Wild type and Model2. d Time versus radius of gyration. e SASA with respect to time. f Observed number of hydrogen bonds with respect to simulation timeBack to article page